According to Samsung Biologics
's latest financial reports the company has a price-to-book ratio of 17.6882.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 5.59 | 1.61% |
2023-12-31 | 5.50 | -14.96% |
2022-12-31 | 6.46 | -45.99% |
2021-12-31 | 12.0 | 0.73% |
2020-12-31 | 11.9 | 80.63% |
2019-12-31 | 6.58 | 6.91% |
2018-12-31 | 6.15 | 0.01% |
2017-12-31 | 6.15 | 151.4% |
2016-12-31 | 2.45 |